Lead by Professor Adrian Martineau, this clinical trial is looking to investigate the potential of Vitamin D to reduce incidence and severity of COVID-19 and other acute respiratory infections.
Strategies to boost the UK population’s immunity to respiratory infections are urgently needed even after the successful development of effective vaccines for COVID-19. There have been recent debates as to whether vitamin D – the ‘sunshine vitamin’ – could play a key role in protecting people from coronavirus; however, definite evidence on this is lacking.
The trial has attracted significant interest from the media and the UK Department of Health and BBC News has also broadcasted a short film about the study:
We are incredibly grateful to all the generous donors and supporters who have helped make this trial possible: Barts Charity, Pharma Nord Ltd, the Fischer Family Trust, DSM Nutritional Products Ltd, the Karl R Pfleger Foundation, the AIM Foundation, Synergy Biologics Ltd, the UK National Institute for Health Research Clinical Research Network, the UKRI Industrial Strategy Challenge Fund, Thornton & Ross Ltd, Warburtons Ltd, Mr Matthew Isaacs (personal donation), and Hyphens Pharma Ltd.
Further information about the trial can be found on our news page.
Latest news from Barts and The London
Find out more on the world-class research undertaken at Barts and The London
Support our research and students by making a one-off or regular donation.